Draft dQM CMS Content Implementation Guide
2025.1.0 - CI Build
Draft dQM CMS Content Implementation Guide, published by cqframework. This guide is not an authorized publication; it is the continuous build for version 2025.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/dqm-content-cms-2025/ and changes regularly. See the Directory of published versions
| system-version | http://snomed.info/sct|http://snomed.info/sct/731000124108 |
| default-canonical-version | CRMI Shareable Library version: 1.0.0 |
| default-canonical-version | CRMI Computable Library version: 1.0.0 |
| default-canonical-version | CRMI Publishable Library version: 1.0.0 |
| default-canonical-version | CRMI Executable Library version: 1.0.0 |
| default-canonical-version | CQL Library version: 2.0.0 |
| default-canonical-version | ELM JSON Library version: 2.0.0 |
| default-canonical-version | ELM XML Library version: 2.0.0 |
| default-valueset-version | Care Services in Long Term Residential Facility version: 20240203 |
| default-valueset-version | Ejection Fraction version: 20170504 |
| default-valueset-version | Heart Failure version: 20210218 |
| default-valueset-version | Heart Transplant version: 20220218 |
| default-valueset-version | Heart Transplant Complications version: 20220218 |
| default-valueset-version | Home Healthcare Services version: 20240110 |
| default-valueset-version | Left Ventricular Assist Device Complications version: 20220218 |
| default-valueset-version | Left Ventricular Assist Device Placement version: 20220218 |
| default-valueset-version | Moderate or Severe version: 20170504 |
| default-valueset-version | Moderate or Severe LVSD version: 20170504 |
| default-valueset-version | Nursing Facility Visit version: 20240110 |
| default-valueset-version | Office Visit version: 20180310 |
| default-valueset-version | Outpatient Consultation version: 20240110 |
| default-valueset-version | Patient Provider Interaction version: 20170504 |
| default-canonical-version | Encounter version: 4.0.1 |
| default-canonical-version | Condition version: 4.0.1 |
| default-canonical-version | Procedure version: 4.0.1 |
| default-valueset-version | Annual Wellness Visit version: 20190315 |
| default-valueset-version | Virtual Encounter version: 20210224 |
| default-valueset-version | Preventive Care Services Established Office Visit, 18 and Up version: 20170504 |
| default-valueset-version | Preventive Care Services Initial Office Visit, 18 and Up version: 20170504 |
| default-valueset-version | Telephone Visits version: 20210220 |
| default-valueset-version | Advanced Illness version: 20190315 |
| default-valueset-version | Dementia Medications version: 20190315 |
| default-valueset-version | Frailty Device version: 20200310 |
| default-valueset-version | Frailty Diagnosis version: 20190315 |
| default-valueset-version | Frailty Encounter version: 20210224 |
| default-valueset-version | Frailty Symptom version: 20190315 |
| default-canonical-version | MedicationRequest version: 4.0.1 |
| default-canonical-version | Medication version: 4.0.1 |
| default-valueset-version | Abnormal Presentation version: 20210611 |
| default-valueset-version | Cesarean Birth version: 20210611 |
| default-valueset-version | Delivery of Singleton version: 20210611 |
| default-valueset-version | Genital Herpes version: 20180310 |
| default-valueset-version | Placental Accreta Spectrum Previa or Vasa Previa version: 20230217 |
| default-valueset-version | 37 to 42 Plus Weeks Gestation version: 20230217 |
| default-valueset-version | Application of Graduated Compression Stockings version: 20220212 |
| default-valueset-version | Application of Intermittent Pneumatic Compression Devices version: 20220212 |
| default-valueset-version | Application of Venous Foot Pumps version: 20220212 |
| default-valueset-version | Atrial Fibrillation or Flutter version: 20240209 |
| default-valueset-version | Comfort Measures version: 20210220 |
| default-valueset-version | Direct Thrombin Inhibitor version: 20240203 |
| default-valueset-version | General or Neuraxial Anesthesia version: 20210220 |
| default-valueset-version | General Surgery version: 20210220 |
| default-valueset-version | Glycoprotein IIb IIIa Inhibitors version: 20230117 |
| default-valueset-version | Graduated compression stockings version: 20240203 |
| default-valueset-version | Gynecological Surgery version: 20210220 |
| default-valueset-version | Hemorrhagic Stroke version: 20210220 |
| default-valueset-version | Ischemic Stroke version: 20210220 |
| default-valueset-version | Hip Fracture Surgery version: 20210220 |
| default-valueset-version | Hip Replacement Surgery version: 20210220 |
| default-valueset-version | Injectable Factor Xa Inhibitor for VTE Prophylaxis version: 20210220 |
| default-valueset-version | INR version: 20210220 |
| default-valueset-version | Intensive Care Unit version: 20210220 |
| default-valueset-version | Intermittent pneumatic compression devices version: 20230117 |
| default-valueset-version | Intracranial Neurosurgery version: 20210220 |
| default-valueset-version | Intravenous route version: 20210220 |
| default-valueset-version | Knee Replacement Surgery version: 20210220 |
| default-valueset-version | Low Dose Unfractionated Heparin for VTE Prophylaxis version: 20240203 |
| default-valueset-version | Low Molecular Weight Heparin for VTE Prophylaxis version: 20230117 |
| default-valueset-version | Low Risk version: 20240203 |
| default-valueset-version | Medical Reason For Not Providing Treatment version: 20220212 |
| default-valueset-version | Mental Health Diagnoses version: 20210220 |
| default-valueset-version | Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment version: 20220212 |
| default-valueset-version | Patient Refusal version: 20230117 |
| default-valueset-version | Rivaroxaban for VTE Prophylaxis version: 20220219 |
| default-valueset-version | Subcutaneous route version: 20210220 |
| default-valueset-version | Unfractionated Heparin version: 20210220 |
| default-valueset-version | Urological Surgery version: 20210220 |
| default-valueset-version | Venous foot pumps version: 20210220 |
| default-valueset-version | Venous Thromboembolism version: 20210220 |
| default-valueset-version | Warfarin version: 20210220 |
| default-canonical-version | ServiceRequest version: 4.0.1 |
| default-canonical-version | MedicationAdministration version: 4.0.1 |
| default-valueset-version | Encounter Inpatient version: 20200307 |
| default-valueset-version | Adolescent Depression Medications version: 20210220 |
| default-valueset-version | Adult Depression Medications version: 20210220 |
| default-valueset-version | Bipolar Disorder version: 20240214 |
| default-valueset-version | Encounter to Screen for Depression version: 20210220 |
| default-valueset-version | Follow Up for Adolescent Depression version: 20210220 |
| default-valueset-version | Follow Up for Adult Depression version: 20210220 |
| default-valueset-version | Medical Reason version: 20170504 |
| default-valueset-version | Physical Therapy Evaluation version: 20200306 |
| default-valueset-version | Referral for Adolescent Depression version: 20200307 |
| default-valueset-version | Referral for Adult Depression version: 20200307 |
| default-valueset-version | Bilateral Mastectomy version: 20240105 |
| default-valueset-version | History of bilateral mastectomy version: 20171219 |
| default-valueset-version | Mammography version: 20210304 |
| default-valueset-version | Status Post Left Mastectomy version: 20171216 |
| default-valueset-version | Status Post Right Mastectomy version: 20171216 |
| default-valueset-version | Unilateral Mastectomy Left version: 20190315 |
| default-valueset-version | Unilateral Mastectomy Right version: 20190315 |
| default-valueset-version | Unilateral Mastectomy, Unspecified Laterality version: 20240112 |
| system-version | RoleCode version: 4.0.0 |
| default-valueset-version | Emergency Department Evaluation and Management Visit version: 20210928 |
| default-valueset-version | Observation Services version: 20210611 |
| default-valueset-version | Colonoscopy version: 20171219 |
| default-valueset-version | CT Colonography version: 20190315 |
| default-valueset-version | Fecal Occult Blood Test (FOBT) version: 20171219 |
| default-valueset-version | sDNA FIT Test version: 20171219 |
| default-valueset-version | Flexible Sigmoidoscopy version: 20171219 |
| default-valueset-version | Malignant Neoplasm of Colon version: 20240112 |
| default-valueset-version | Total Colectomy version: 20240112 |
| default-valueset-version | ACE Inhibitor or ARB or ARNI Ingredient version: 20230217 |
| default-valueset-version | ACE Inhibitor or ARB or ARNI version: 20210218 |
| default-valueset-version | Allergy to ACE Inhibitor or ARB version: 20170908 |
| default-valueset-version | Intolerance to ACE Inhibitor or ARB version: 20170504 |
| default-valueset-version | Patient Reason version: 20170504 |
| default-valueset-version | Patient Reason for ACE Inhibitor or ARB Decline version: 20170504 |
| default-valueset-version | Pregnancy version: 20210218 |
| default-canonical-version | AllergyIntolerance version: 4.0.1 |
| default-canonical-version | US Core Observation Pregnancy Status Profile version: 7.0.0 |
| default-valueset-version | Acute Pharyngitis version: 20170504 |
| default-valueset-version | Acute Tonsillitis version: 20170504 |
| default-valueset-version | Antibiotic Medications for Pharyngitis version: 20170504 |
| default-valueset-version | Comorbid Conditions for Respiratory Conditions version: 20220928 |
| default-valueset-version | Competing Conditions for Respiratory Conditions version: 20210220 |
| default-valueset-version | Group A Streptococcus Test version: 20170504 |
| default-valueset-version | Medical Disability Exam version: 20210306 |
| default-valueset-version | Preventive Care Services Group Counseling version: 20170504 |
| default-valueset-version | Preventive Care Services Individual Counseling version: 20170504 |
| default-valueset-version | Preventive Care Services, Initial Office Visit, 0 to 17 version: 20170504 |
| default-valueset-version | Preventive Care, Established Office Visit, 0 to 17 version: 20170504 |
| default-valueset-version | Chronic Kidney Disease, Stage 5 version: 20200307 |
| default-valueset-version | Dialysis Services version: 20170504 |
| default-valueset-version | End Stage Renal Disease version: 20200307 |
| default-valueset-version | ESRD Monthly Outpatient Services version: 20170504 |
| default-valueset-version | Essential Hypertension version: 20240106 |
| default-valueset-version | Kidney Transplant version: 20190315 |
| default-valueset-version | Kidney Transplant Recipient version: 20240112 |
| default-canonical-version | US Core Blood Pressure Profile version: 7.0.0 |
| default-valueset-version | Hospice Care Referral or Admission version: 20191010 |
| default-valueset-version | Hospital Dietitian Referral version: 20221116 |
| default-valueset-version | Malnutrition Diagnosis version: 20180616 |
| default-valueset-version | Malnutrition Risk Screening version: 20240117 |
| default-valueset-version | Malnutrition Screening Finding of At Risk Result version: 20240117 |
| default-valueset-version | Malnutrition Screening Finding of Not At Risk Result version: 20240117 |
| default-valueset-version | Nutrition Assessment version: 20240117 |
| default-valueset-version | Nutrition Assessment Status Finding of Moderately Malnourished version: 20240117 |
| default-valueset-version | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished version: 20240117 |
| default-valueset-version | Nutrition Assessment Status Finding of Severely Malnourished version: 20240117 |
| default-valueset-version | Nutrition Care Plan version: 20240117 |
| system-version | Diagnosis Role version: 1.1.1 |
| system-version | Example Diagnosis Type Codes version: 1.0.1 |
| system-version | Example Procedure Type Codes version: 1.0.1 |
| system-version | CMS Present on Admission (POA) Indicator version: 07/14/2020 |
| default-valueset-version | Emergency Department Visit version: 20210611 |
| default-valueset-version | Outpatient Surgery Service version: 20190426 |
| default-valueset-version | Present on Admission or Clinically Undetermined version: 20220415 |
| default-canonical-version | Location version: 4.0.1 |
| default-canonical-version | Claim version: 4.0.1 |
| default-valueset-version | Hospice Care Ambulatory version: 20210825 |
| default-valueset-version | Hospice Encounter version: 20210820 |
| default-valueset-version | Hospice Diagnosis version: 20220818 |
| system-version | ActCode version: 10.0.0 |
| default-valueset-version | Blood Glucose Laboratory and Point of Care Tests version: 20230902 |
| default-valueset-version | Diabetes Medications version: 20220304 |
| default-valueset-version | Inpatient, Emergency, and Observation Locations version: 20220720 |
| default-valueset-version | NHSN Inpatient Encounter Class Codes version: 20240409 |
| default-canonical-version | Coverage version: 4.0.1 |
| default-canonical-version | Patient version: 4.0.1 |
| default-valueset-version | Delivery Procedures version: 20210611 |
| default-valueset-version | ED Visit and OB Triage version: 20210611 |
| default-valueset-version | Estimated Gestational Age at Delivery version: 20210611 |
| default-valueset-version | Palliative Care Encounter version: 20210224 |
| default-valueset-version | Palliative Care Intervention version: 20210224 |
| default-valueset-version | Palliative Care Diagnosis version: 20220820 |
| system-version | Observation Category Codes version: 2.0.0 |
| system-version | ConditionVerificationStatus version: 2.0.1 |
| default-valueset-version | Ethnicity version: 20121025 |
| default-valueset-version | Payer Type version: 20221118 |
| default-valueset-version | Race version: 20121025 |
| default-valueset-version | Discharge To Acute Care Facility version: 20210611 |
| default-valueset-version | Discharged to Health Care Facility for Hospice Care version: 20210611 |
| default-valueset-version | Discharged to Home for Hospice Care version: 20210220 |
| default-valueset-version | Left Against Medical Advice version: 20210220 |
| default-valueset-version | Nonelective Inpatient Encounter version: 20210220 |
| default-valueset-version | Patient Expired version: 20210611 |
| system-version | Task Codes version: 4.0.1 |
| system-version | AllergyIntolerance Clinical Status Codes version: 1.0.1 |
| system-version | AllergyIntolerance Verification Status version: 1.0.1 |
| default-valueset-version | Obstetrical or Pregnancy Related Conditions version: 20210220 |
| default-valueset-version | Obstetrics VTE version: 20210220 |
| default-canonical-version | CRMI Shareable Measure version: 1.0.0 |
| default-canonical-version | CQFM Computable Measure version: 4.0.0 |
| default-canonical-version | CQFM Publishable Measure version: 4.0.0 |
| default-canonical-version | CQFM Executable Measure version: 4.0.0 |
| default-canonical-version | CQFM CQL Measure version: 4.0.0 |
| default-canonical-version | CQFM ELM Measure version: 4.0.0 |
| default-canonical-version | CQFM Proportion Measure version: 4.0.0 |
| default-canonical-version | CMS0334FHIRPCCesareanBirth version: 1.1.000 |
| default-canonical-version | CQFM Ratio Measure version: 4.0.0 |
| system-version | MedicationRequest Category Codes version: 2.0.0 |
| default-valueset-version | Osteoporosis version: 20201204 |
| default-valueset-version | Coagulation Disorders version: 20240112 |
| default-valueset-version | Antidepressants version: 20240119 |
| default-valueset-version | Not Present On Admission or Documentation Insufficient to Determine version: 20220415 |
| default-valueset-version | Leukemia or Lymphoma version: 20221006 |
| default-valueset-version | Obesity version: 20221006 |
| default-valueset-version | Peripheral Neuropathy version: 20221006 |
| default-valueset-version | Delirium or Dementia and Other Psychoses version: 20221006 |
| default-valueset-version | Suicide Attempt version: 20230425 |
| default-valueset-version | Liver Disease Moderate to Severe version: 20221006 |
| default-valueset-version | Anticoagulants for All Indications version: 20220608 |
| default-valueset-version | Neurologic Movement and Related Disorders version: 20221006 |
| default-valueset-version | Depression version: 20221006 |
| default-valueset-version | Epilepsy version: 20240112 |
| default-valueset-version | Diuretics version: 20240118 |
| default-valueset-version | Central Nervous System Depressants version: 20240119 |
| default-valueset-version | Malignant Bone Disease version: 20221006 |
| default-valueset-version | Antihypertensives version: 20240120 |
| default-valueset-version | Opioids version: 20240124 |
| default-valueset-version | Inpatient Falls version: 20210605 |
| default-valueset-version | Major Injuries version: 20240112 |
| default-valueset-version | Moderate Injuries version: 20240112 |
| default-valueset-version | Stroke version: 20240112 |
| default-canonical-version | Resource version: 4.0.1 |
| default-canonical-version | US Core BMI Profile version: 7.0.0 |
| default-canonical-version | AdverseEvent version: 4.0.1 |
| default-valueset-version | 20 to 42 Plus Weeks Gestation version: 20230217 |
| default-valueset-version | Acute or Persistent Asthma version: 20220127 |
| default-valueset-version | Present On Admission is Yes or Exempt version: 20220127 |
| default-valueset-version | Severe Maternal Morbidity Diagnoses version: 20220127 |
| default-valueset-version | Present on Admission is No or Unable To Determine version: 20220127 |
| default-valueset-version | Severe Maternal Morbidity Procedures version: 20230218 |
| default-valueset-version | Blood Transfusion version: 20220127 |
| default-valueset-version | Placenta Increta or Percreta version: 20240223 |
| default-valueset-version | Hysterectomy version: 20210121 |
| default-valueset-version | Conversion of Cardiac Rhythm version: 20210121 |
| default-valueset-version | Tracheostomy version: 20210121 |
| default-valueset-version | Ventilation version: 20210121 |
| default-valueset-version | Placenta Accreta version: 20220127 |
| default-valueset-version | Hypertension version: 20220127 |
| default-valueset-version | Placental Abruption version: 20220127 |
| default-valueset-version | Morbid or Severe Obesity version: 20220127 |
| default-valueset-version | Preexisting Diabetes version: 20220127 |
| default-valueset-version | Bariatric Surgery version: 20220127 |
| default-valueset-version | Placenta Previa version: 20231111 |
| default-valueset-version | Bleeding Disorder version: 20220127 |
| default-valueset-version | White blood cells count lab test version: 20230214 |
| default-valueset-version | Hematocrit lab test version: 20230214 |
| default-valueset-version | Anemia version: 20220127 |
| default-valueset-version | Severe Preeclampsia version: 20220127 |
| default-valueset-version | Cardiac Disease version: 20220127 |
| default-valueset-version | Long Term Anticoagulant Use version: 20220127 |
| default-valueset-version | Acute Heart Failure version: 20220127 |
| default-valueset-version | Acute Myocardial Infarction version: 20240210 |
| default-valueset-version | Acute Renal Failure version: 20240210 |
| default-valueset-version | Acute Respiratory Distress Syndrome version: 20220127 |
| default-valueset-version | Air and Thrombotic Embolism version: 20220127 |
| default-valueset-version | Amniotic Fluid Embolism version: 20220127 |
| default-valueset-version | Aortic Aneurysm version: 20230217 |
| default-valueset-version | Cardiac Arrest Ventricular Fibrillation version: 20220127 |
| default-valueset-version | Disseminated Intravascular Coagulation version: 20230217 |
| default-valueset-version | Eclampsia version: 20220127 |
| default-valueset-version | Heart Failure Cardiac Arrest Related to Procedure or Surgery version: 20220127 |
| default-valueset-version | Puerperal Cerebrovascular Disorder version: 20230217 |
| default-valueset-version | Pulmonary Edema version: 20220127 |
| default-valueset-version | Sepsis version: 20240210 |
| default-valueset-version | Severe Anesthesia Complications version: 20220127 |
| default-valueset-version | Shock version: 20220127 |
| default-valueset-version | Sickle Cell Disease with Crisis version: 20240210 |
| default-valueset-version | Substance Abuse version: 20220127 |
| default-valueset-version | Renal Disease version: 20220127 |
| default-valueset-version | Gastrointestinal Disease version: 20220127 |
| default-valueset-version | Pulmonary Hypertension version: 20220127 |
| default-valueset-version | Mild or Moderate Preeclampsia version: 20220127 |
| default-valueset-version | Thyrotoxicosis version: 20220127 |
| default-valueset-version | Neuromuscular Disease version: 20220127 |
| default-valueset-version | Economic Housing Instability version: 20220127 |
| default-valueset-version | HIV in Pregnancy Childbirth and Puerperium version: 20220127 |
| default-valueset-version | Mental Health Disorder version: 20220127 |
| default-valueset-version | Venous Thromboembolism in Pregnancy version: 20220127 |
| default-valueset-version | Autoimmune Disease version: 20220127 |
| default-valueset-version | Previous Cesarean version: 20220316 |
| default-valueset-version | Gestational Diabetes version: 20220127 |
| default-valueset-version | Multiple Pregnancy version: 20220127 |
| default-canonical-version | US Core Heart Rate Profile version: 7.0.0 |
| default-valueset-version | Antithrombotic Therapy for Ischemic Stroke version: 20210409 |
| default-valueset-version | Pharmacological Contraindications For Antithrombotic Therapy version: 20220219 |
| system-version | Condition Clinical Status Codes version: 3.0.0 |
| default-canonical-version | CMS108FHIRVTEProphylaxis version: 1.1.000 |
| default-valueset-version | Glycemic Screening Tests version: 20230107 |
| default-valueset-version | Preventative Care Encounter to Screen for for Diabetes version: 20230107 |
| default-valueset-version | Office Visit Encounter to Screen for Diabetes version: 20230107 |
| default-valueset-version | Limited Life Expectancy version: 20170504 |
| default-valueset-version | Diabetes version: 20220924 |
| default-valueset-version | Prediabetes (Borderline Diabetes) version: 20210519 |
| default-valueset-version | Preventive Care Services Other version: 20170826 |
| default-valueset-version | HIV version: 20240106 |
| default-valueset-version | Outpatient Encounter version: 20210220 |
| default-valueset-version | VTE Diagnoses version: 20220630 |
| default-valueset-version | VTE Symptoms version: 20220301 |
| default-valueset-version | Imaging Related to VTE version: 20230105 |
| default-valueset-version | Anticoagulant Medications version: 20240306 |
| default-valueset-version | Hospice Care Ambulatory version: 20240207 |
| default-valueset-version | DTaP Vaccine version: 20170504 |
| default-valueset-version | DTaP Vaccine Administered version: 20170504 |
| default-valueset-version | Anaphylactic Reaction to DTaP Vaccine version: 20170504 |
| default-valueset-version | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine version: 20220208 |
| default-valueset-version | Inactivated Polio Vaccine (IPV) version: 20170504 |
| default-valueset-version | Inactivated Polio Vaccine (IPV) Administered version: 20170504 |
| default-valueset-version | Measles, Mumps and Rubella (MMR) Vaccine version: 20170504 |
| default-valueset-version | Measles, Mumps and Rubella (MMR) Vaccine Administered version: 20170504 |
| default-valueset-version | Measles version: 20170504 |
| default-valueset-version | Mumps version: 20170504 |
| default-valueset-version | Rubella version: 20170504 |
| default-valueset-version | Hib Vaccine (3 dose schedule) version: 20190315 |
| default-valueset-version | Hib Vaccine (3 dose schedule) Administered version: 20190315 |
| default-valueset-version | Hib Vaccine (4 dose schedule) version: 20190315 |
| default-valueset-version | Hib Vaccine (4 dose schedule) Administered version: 20190315 |
| default-valueset-version | Hepatitis B Vaccine version: 20170504 |
| default-valueset-version | Hepatitis B Vaccine Administered version: 20220909 |
| default-valueset-version | Hepatitis B version: 20170504 |
| default-valueset-version | Varicella Zoster Vaccine (VZV) version: 20170504 |
| default-valueset-version | Varicella Zoster Vaccine (VZV) Administered version: 20170504 |
| default-valueset-version | Varicella Zoster version: 20170504 |
| default-valueset-version | Pneumococcal Conjugate Vaccine version: 20170504 |
| default-valueset-version | Pneumococcal Conjugate Vaccine Administered version: 20170504 |
| default-valueset-version | Hepatitis A Vaccine version: 20170504 |
| default-valueset-version | Hepatitis A Vaccine Administered version: 20170504 |
| default-valueset-version | Hepatitis A version: 20170504 |
| default-valueset-version | Rotavirus Vaccine (2 dose schedule) Administered version: 20190315 |
| default-valueset-version | Rotavirus Vaccine (3 dose schedule) version: 20170504 |
| default-valueset-version | Rotavirus Vaccine (3 dose schedule) Administered version: 20190316 |
| default-valueset-version | Child Influenza Immunization Administered version: 20170504 |
| default-valueset-version | Child Influenza Vaccine Administered version: 20170504 |
| default-valueset-version | Influenza Virus LAIV Immunization version: 20210224 |
| default-valueset-version | Influenza Virus LAIV Procedure version: 20210224 |
| default-valueset-version | Severe Combined Immunodeficiency version: 20170504 |
| default-valueset-version | Disorders of the Immune System version: 20170504 |
| default-valueset-version | Malignant Neoplasm of Lymphatic and Hematopoietic Tissue version: 20170504 |
| default-valueset-version | Intussusception version: 20170504 |
| default-canonical-version | Immunization version: 4.0.1 |
| default-valueset-version | Chlamydia Screening version: 20170504 |
| default-valueset-version | Gonorrhea Screening version: 20240130 |
| default-canonical-version | CMS1206FHIRCTOQR version: 1.1.000 |
| default-valueset-version | Elective Inpatient Encounter version: 20230518 |
| default-valueset-version | General and Neuraxial Anesthesia version: 20230429 |
| default-valueset-version | Albumin lab test version: 20230520 |
| default-valueset-version | Arterial Blood pH version: 20240109 |
| default-valueset-version | Carbon Dioxide Partial Pressure in Arterial Blood version: 20240109 |
| default-valueset-version | Hemoglobin lab test version: 20230512 |
| default-valueset-version | Sodium lab test version: 20220218 |
| default-valueset-version | Creatinine lab test version: 20230214 |
| default-valueset-version | ASA physical status class version: 20230512 |
| default-valueset-version | Bicarbonate lab test version: 20230214 |
| default-valueset-version | Bilirubin lab test version: 20240112 |
| default-valueset-version | Oxygen Partial Pressure in Arterial Blood version: 20240109 |
| default-valueset-version | Leukocyte count lab test version: 20240112 |
| default-valueset-version | Intubation version: 20220719 |
| default-valueset-version | Anesthesia Requiring Monitored Care version: 20240112 |
| default-valueset-version | Mechanical Ventilation version: 20220507 |
| default-valueset-version | Non Invasive Oxygen Therapy by Nasal Cannula or Mask version: 20240112 |
| default-valueset-version | Non Invasive Oxygen Therapy version: 20230512 |
| default-valueset-version | Blood urea nitrogen lab test version: 20240112 |
| default-valueset-version | Degenerative Neurological Disorder version: 20230923 |
| default-valueset-version | Head, Neck, and Thoracic Surgeries with High Risk Airway Compromise version: 20240112 |
| default-valueset-version | Neuromuscular Disorder version: 20230923 |
| default-valueset-version | Acute Respiratory Failure version: 20230426 |
| default-valueset-version | Tracheostomy Diagnoses version: 20220719 |
| default-valueset-version | Tracheostomy Procedures version: 20220719 |
| default-valueset-version | Aspartate transaminase lab test version: 20230520 |
| default-valueset-version | Platelet count lab test version: 20230214 |
| default-canonical-version | US Core Respiratory Rate Profile version: 7.0.0 |
| default-canonical-version | US Core Body Temperature Profile version: 7.0.0 |
| default-valueset-version | HbA1c Laboratory Test version: 20170504 |
| default-valueset-version | Nutrition Services version: 20210819 |
| default-canonical-version | CMS122FHIRDiabetesAssessGT9Pct version: 1.1.000 |
| default-valueset-version | Decision to Admit to Hospital Inpatient version: 20210220 |
| default-valueset-version | Emergency Department Evaluation version: 20200305 |
| default-valueset-version | Admit Inpatient version: 20210220 |
| default-valueset-version | Pap Test version: 20170504 |
| default-valueset-version | HPV Test version: 20170504 |
| default-valueset-version | Hysterectomy with No Residual Cervix version: 20240112 |
| default-valueset-version | Congenital or Acquired Absence of Cervix version: 20240106 |
| default-canonical-version | CMS125FHIRBreastCancerScreen version: 1.1.000 |
| default-canonical-version | CMS1264FHIRECATREHQR version: 1.1.000 |
| default-valueset-version | Antidepressant Medication version: 20210306 |
| default-valueset-version | Major Depression version: 20170504 |
| default-valueset-version | Psych Visit Diagnostic Evaluation version: 20190315 |
| default-valueset-version | Psych Visit Psychotherapy version: 20190315 |
| default-canonical-version | MedicationDispense version: 4.0.1 |
| default-valueset-version | Bone Scan version: 20240130 |
| default-valueset-version | Prostate Cancer version: 20200306 |
| default-valueset-version | Prostate Cancer Treatment version: 20170504 |
| default-valueset-version | Prostate Specific Antigen Test version: 20170504 |
| default-valueset-version | Pain Warranting Further Investigation for Prostate Cancer version: 20200306 |
| default-valueset-version | Salvage Therapy version: 20170504 |
| default-canonical-version | CMS130FHIRColorectalCancerScrn version: 1.1.000 |
| default-valueset-version | Diabetic Retinopathy version: 20210218 |
| default-valueset-version | Retinal or Dilated Eye Exam version: 20170504 |
| default-valueset-version | Ophthalmological Services version: 20210209 |
| default-valueset-version | Cataract Surgery version: 20210210 |
| default-valueset-version | Best Corrected Visual Acuity Exam Using Snellen Chart version: 20210210 |
| default-valueset-version | Visual Acuity 20/40 or Better version: 20210214 |
| default-valueset-version | Acute and Subacute Iridocyclitis version: 20210210 |
| default-valueset-version | Amblyopia version: 20210210 |
| default-valueset-version | Burn Confined to Eye and Adnexa version: 20210210 |
| default-valueset-version | Cataract Secondary to Ocular Disorders version: 20210210 |
| default-valueset-version | Cataract Congenital version: 20210210 |
| default-valueset-version | Cataract Mature or Hypermature version: 20210210 |
| default-valueset-version | Cataract Posterior Polar version: 20210210 |
| default-valueset-version | Central Corneal Ulcer version: 20210210 |
| default-valueset-version | Certain Types of Iridocyclitis version: 20210210 |
| default-valueset-version | Choroidal Degenerations version: 20210210 |
| default-valueset-version | Choroidal Detachment version: 20210210 |
| default-valueset-version | Choroidal Hemorrhage and Rupture version: 20210210 |
| default-valueset-version | Chronic Iridocyclitis version: 20210210 |
| default-valueset-version | Cloudy Cornea version: 20210210 |
| default-valueset-version | Corneal Edema version: 20210210 |
| default-valueset-version | Disorders of Cornea Including Corneal Opacity version: 20210210 |
| default-valueset-version | Degeneration of Macula and Posterior Pole version: 20210210 |
| default-valueset-version | Degenerative Disorders of Globe version: 20210214 |
| default-valueset-version | Diabetic Macular Edema version: 20210214 |
| default-valueset-version | Disorders of Optic Chiasm version: 20210214 |
| default-valueset-version | Disorders of Visual Cortex version: 20210214 |
| default-valueset-version | Disseminated Chorioretinitis and Disseminated Retinochoroiditis version: 20210214 |
| default-valueset-version | Focal Chorioretinitis and Focal Retinochoroiditis version: 20210214 |
| default-valueset-version | Glaucoma version: 20210218 |
| default-valueset-version | Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes version: 20210214 |
| default-valueset-version | Hereditary Choroidal Dystrophies version: 20210214 |
| default-valueset-version | Hereditary Corneal Dystrophies version: 20210214 |
| default-valueset-version | Hereditary Retinal Dystrophies version: 20210219 |
| default-valueset-version | Hypotony of Eye version: 20210214 |
| default-valueset-version | Injury to Optic Nerve and Pathways version: 20210214 |
| default-valueset-version | Macular Scar of Posterior Polar version: 20210218 |
| default-valueset-version | Morgagnian Cataract version: 20210214 |
| default-valueset-version | Nystagmus and Other Irregular Eye Movements version: 20210308 |
| default-valueset-version | Open Wound of Eyeball version: 20210406 |
| default-valueset-version | Optic Atrophy version: 20210218 |
| default-valueset-version | Optic Neuritis version: 20210218 |
| default-valueset-version | Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis version: 20210219 |
| default-valueset-version | Other Background Retinopathy and Retinal Vascular Changes version: 20210218 |
| default-valueset-version | Other Disorders of Optic Nerve version: 20210218 |
| default-valueset-version | Other Endophthalmitis version: 20210218 |
| default-valueset-version | Other Proliferative Retinopathy version: 20210218 |
| default-valueset-version | Pathologic Myopia version: 20210218 |
| default-valueset-version | Posterior Lenticonus version: 20210314 |
| default-valueset-version | Prior Penetrating Keratoplasty version: 20210218 |
| default-valueset-version | Purulent Endophthalmitis version: 20210218 |
| default-valueset-version | Retinal Detachment with Retinal Defect version: 20210218 |
| default-valueset-version | Retinal Vascular Occlusion version: 20210218 |
| default-valueset-version | Retrolental Fibroplasias version: 20210218 |
| default-valueset-version | Scleritis version: 20210308 |
| default-valueset-version | Separation of Retinal Layers version: 20210218 |
| default-valueset-version | Traumatic Cataract version: 20210219 |
| default-valueset-version | Uveitis version: 20210219 |
| default-valueset-version | Vascular Disorders of Iris and Ciliary Body version: 20210214 |
| default-valueset-version | Visual Field Defects version: 20210220 |
| default-canonical-version | CMS135FHIRACEIorARBorARNIforHF version: 1.1.000 |
| default-valueset-version | Atomoxetine version: 20220902 |
| default-valueset-version | Clonidine version: 20240119 |
| default-valueset-version | Dexmethylphenidate version: 20220902 |
| default-valueset-version | Dextroamphetamine version: 20220902 |
| default-valueset-version | Lisdexamfetamine version: 20220902 |
| default-valueset-version | Methylphenidate version: 20240123 |
| default-valueset-version | Guanfacine Medications version: 20240123 |
| default-valueset-version | Mental Behavioral and Neurodevelopmental Disorders version: 20210224 |
| default-valueset-version | Behavioral Health Follow up Visit version: 20170504 |
| default-valueset-version | Psychotherapy and Pharmacologic Management version: 20170504 |
| default-valueset-version | Ambulatory version: 20170504 |
| default-valueset-version | Narcolepsy version: 20240112 |
| default-valueset-version | Detoxification Visit version: 20170504 |
| default-valueset-version | Initial Hospital Inpatient Visit version: 20170504 |
| default-valueset-version | Discharge Services Hospital Inpatient Same Day Discharge version: 20170504 |
| default-valueset-version | Discharge Services Hospital Inpatient version: 20170504 |
| default-valueset-version | Substance Use Disorder version: 20170504 |
| default-valueset-version | Substance Use Disorder Treatment version: 20210220 |
| default-valueset-version | Substance Use Disorder Long Acting Medication Administration version: 20211102 |
| default-valueset-version | Substance Use Disorder Short Acting Medication Administration version: 20211102 |
| default-valueset-version | Substance Use Disorder Long Acting Medication version: 20240124 |
| default-valueset-version | Substance Use Disorder Short Acting Medication version: 20240124 |
| default-valueset-version | Occupational Therapy Evaluation version: 20190315 |
| default-valueset-version | Psychoanalysis version: 20190315 |
| default-valueset-version | Speech and Hearing Evaluation version: 20190315 |
| default-valueset-version | Tobacco Non User version: 20170504 |
| default-valueset-version | Tobacco User version: 20170504 |
| default-valueset-version | Tobacco Use Cessation Counseling version: 20170504 |
| default-valueset-version | Tobacco Use Cessation Pharmacotherapy version: 20170504 |
| default-canonical-version | US Core Smoking Status Observation Profile version: 7.0.0 |
| default-valueset-version | Falls Screening version: 20190315 |
| default-valueset-version | Discharge Services Nursing Facility version: 20170504 |
| default-valueset-version | Audiology Visit version: 20170504 |
| default-valueset-version | Level of Severity of Retinopathy Findings version: 20210209 |
| default-valueset-version | Macular Edema Findings Absent version: 20130614 |
| default-valueset-version | Macular Edema Findings Present version: 20210209 |
| default-valueset-version | Macular Exam version: 20210209 |
| default-canonical-version | Communication version: 4.0.1 |
| default-valueset-version | Cup to Disc Ratio version: 20210209 |
| default-valueset-version | Primary Open Angle Glaucoma version: 20210209 |
| default-valueset-version | Optic Disc Exam for Structural Abnormalities version: 20210209 |
| default-valueset-version | Beta Blocker Therapy for LVSD version: 20170504 |
| default-valueset-version | Arrhythmia version: 20200306 |
| default-valueset-version | Hypotension version: 20200306 |
| default-valueset-version | Asthma version: 20200306 |
| default-valueset-version | Allergy to Beta Blocker Therapy version: 20170504 |
| default-valueset-version | Intolerance to Beta Blocker Therapy version: 20170504 |
| default-valueset-version | Bradycardia version: 20200306 |
| default-valueset-version | Beta Blocker Therapy Ingredient version: 20170504 |
| default-valueset-version | Atrioventricular Block version: 20210218 |
| default-valueset-version | Cardiac Pacer in Situ version: 20210218 |
| default-valueset-version | Cardiac Pacer version: 20220218 |
| default-valueset-version | Coronary Artery Disease No MI version: 20200306 |
| default-valueset-version | Cardiac Surgery version: 20210218 |
| default-valueset-version | Initial Myocardial Infarction version: 20240125 |
| default-valueset-version | Beta Blocker Therapy version: 20210303 |
| default-canonical-version | CMS146FHIRApproTestPharyngitis version: 1.1.000 |
| default-valueset-version | Standardized Tools Score for Assessment of Cognition version: 20170504 |
| default-valueset-version | Cognitive Assessment version: 20170504 |
| default-valueset-version | Behavioral/Neuropsych Assessment version: 20190315 |
| default-valueset-version | Dementia & Mental Degenerations version: 20200306 |
| default-valueset-version | Diagnoses Used to Indicate Sexual Activity version: 20210224 |
| default-valueset-version | Complications of Pregnancy, Childbirth and the Puerperium version: 20200310 |
| default-valueset-version | Contraceptive Medications version: 20170504 |
| default-valueset-version | Pregnancy Test version: 20170504 |
| default-valueset-version | Lab Tests During Pregnancy version: 20170504 |
| default-valueset-version | Lab Tests for Sexually Transmitted Infections version: 20170504 |
| default-valueset-version | Diagnostic Studies During Pregnancy version: 20170504 |
| default-valueset-version | Procedures Used to Indicate Sexual Activity version: 20210220 |
| default-valueset-version | XRay Study version: 20170504 |
| default-valueset-version | Isotretinoin version: 20170504 |
| default-valueset-version | Upper Respiratory Infection version: 20170504 |
| default-valueset-version | Counseling for Physical Activity version: 20170504 |
| default-valueset-version | Counseling for Nutrition version: 20170504 |
| default-canonical-version | US Core Pediatric BMI for Age Observation Profile version: 7.0.0 |
| default-canonical-version | US Core Body Height Profile version: 7.0.0 |
| default-canonical-version | US Core Body Weight Profile version: 7.0.0 |
| default-valueset-version | Antipsychotic version: 20220213 |
| default-valueset-version | Schizophrenia version: 20210224 |
| default-valueset-version | Benzodiazepine version: 20220212 |
| default-valueset-version | Seizure Disorder version: 20210224 |
| default-valueset-version | REM Sleep Behavior Disorder version: 20210224 |
| default-valueset-version | Benzodiazepine Withdrawal version: 20210224 |
| default-valueset-version | Alcohol Withdrawal version: 20210224 |
| default-valueset-version | Generalized Anxiety Disorder version: 20210224 |
| default-valueset-version | Potentially Harmful Antihistamines for Older Adults version: 20240120 |
| default-valueset-version | Potentially Harmful Antiparkinsonian Agents for Older Adults version: 20240123 |
| default-valueset-version | Potentially Harmful Gastrointestinal Antispasmodics for Older Adults version: 20240123 |
| default-valueset-version | Antithrombotic version: 20210909 |
| default-valueset-version | Nifedipine Medications version: 20240117 |
| default-valueset-version | Potentially Harmful Antidepressants for Older Adults version: 20240120 |
| default-valueset-version | Potentially Harmful Barbiturates for Older Adults version: 20240123 |
| default-valueset-version | Central nervous system, other version: 20210909 |
| default-valueset-version | Potentially Harmful Estrogens for Older Adults version: 20240123 |
| default-valueset-version | Potentially Harmful Sulfonylureas for Older Adults version: 20240123 |
| default-valueset-version | Desiccated Thyroid Medications version: 20240117 |
| default-valueset-version | Nonbenzodiazepine hypnotics version: 20170504 |
| default-valueset-version | Potentially Harmful Skeletal Muscle Relaxants for Older Adults version: 20240123 |
| default-valueset-version | Potentially Harmful Pain Medications for Older Adults version: 20240123 |
| default-valueset-version | Megestrol Medications version: 20240110 |
| default-valueset-version | Meperidine Medications version: 20240110 |
| default-valueset-version | Anti Infectives, other version: 20170504 |
| default-valueset-version | Digoxin version: 20210910 |
| default-valueset-version | Doxepin version: 20210910 |
| default-valueset-version | Radiation Treatment Management version: 20170504 |
| default-valueset-version | Cancer version: 20200306 |
| default-valueset-version | Audio Visual Telehealth Encounter version: 20201028 |
| default-valueset-version | Chemotherapy Administration version: 20240131 |
| default-valueset-version | Standardized Pain Assessment Tool version: 20170504 |
| default-valueset-version | PHQ 9 and PHQ 9M Tools version: 20220219 |
| default-valueset-version | Contact or Office Visit version: 20220219 |
| default-valueset-version | Major Depression Including Remission version: 20210219 |
| default-valueset-version | Dysthymia version: 20220219 |
| default-valueset-version | Personality Disorder Emotionally Labile version: 20240214 |
| default-valueset-version | Schizophrenia or Psychotic Disorder version: 20240214 |
| default-valueset-version | Pervasive Developmental Disorder version: 20240210 |
| default-canonical-version | CMS165FHIRControllingHighBP version: 1.1.000 |
| default-valueset-version | Psych Visit for Family Psychotherapy version: 20210220 |
| default-valueset-version | Group Psychotherapy version: 20210220 |
| default-valueset-version | Major Depressive Disorder Active version: 20210220 |
| default-valueset-version | Encounter to Screen for Blood Pressure version: 20210220 |
| default-valueset-version | Follow Up Within 6 Months version: 20240125 |
| default-valueset-version | Lifestyle Recommendation version: 20200307 |
| default-valueset-version | Weight Reduction Recommended version: 20210220 |
| default-valueset-version | Dietary Recommendations version: 20210220 |
| default-valueset-version | Recommendation to Increase Physical Activity version: 20190313 |
| default-valueset-version | Referral or Counseling for Alcohol Consumption version: 20200307 |
| default-valueset-version | Referral to Primary Care or Alternate Provider version: 20210220 |
| default-valueset-version | Finding of Elevated Blood Pressure or Hypertension version: 20190313 |
| default-valueset-version | Follow Up Within 4 Weeks version: 20200307 |
| default-valueset-version | Laboratory Tests for Hypertension version: 20170504 |
| default-valueset-version | Pharmacologic Therapy for Hypertension version: 20210220 |
| default-valueset-version | Diagnosis of Hypertension version: 20240206 |
| default-valueset-version | Patient Declined version: 20200307 |
| default-canonical-version | CMS2FHIRPCSDepScreenAndFollowUp version: 1.1.000 |
| default-valueset-version | Myocardial Infarction version: 20240208 |
| default-valueset-version | Cerebrovascular Disease Stroke or TIA version: 20240208 |
| default-valueset-version | Atherosclerosis and Peripheral Arterial Disease version: 20240208 |
| default-valueset-version | Ischemic Heart Disease or Related Diagnoses version: 20240208 |
| default-valueset-version | Stable and Unstable Angina version: 20240208 |
| default-valueset-version | PCI version: 20170504 |
| default-valueset-version | CABG Surgeries version: 20240208 |
| default-valueset-version | Carotid Intervention version: 20240208 |
| default-valueset-version | CABG or PCI Procedure version: 20180818 |
| default-valueset-version | Outpatient Encounters for Preventive Care version: 20200307 |
| default-valueset-version | LDL Cholesterol version: 20200307 |
| default-valueset-version | Familial Hypercholesterolemia version: 20210220 |
| default-valueset-version | Low Intensity Statin Therapy version: 20210220 |
| default-valueset-version | Moderate Intensity Statin Therapy version: 20210220 |
| default-valueset-version | High Intensity Statin Therapy version: 20210220 |
| default-valueset-version | Breastfeeding version: 20210220 |
| default-valueset-version | Rhabdomyolysis version: 20170504 |
| default-valueset-version | Statin Allergen version: 20210220 |
| default-valueset-version | Hepatitis B version: 20170825 |
| default-valueset-version | Liver Disease version: 20210220 |
| default-valueset-version | Statin Associated Muscle Symptoms version: 20240208 |
| default-valueset-version | HIV Lab Tests version: 20240207 |
| default-valueset-version | Schedule II, III and IV Opioid Medications version: 20240215 |
| default-valueset-version | Schedule IV Benzodiazepines version: 20240215 |
| default-valueset-version | Cancer Related Pain version: 20240215 |
| default-valueset-version | Sickle Cell Disease with and without Crisis version: 20240215 |
| default-valueset-version | Medications for Opioid Use Disorder (MOUD) version: 20240215 |
| default-valueset-version | Opioid Medication Assisted Treatment (MAT) version: 20240215 |
| default-valueset-version | Opioid Use Disorder version: 20240215 |
| default-valueset-version | Palliative or Hospice Care version: 20210224 |
| default-valueset-version | Referral version: 20170504 |
| default-valueset-version | Consultant Report version: 20190315 |
| default-canonical-version | Task version: 4.0.1 |
| default-valueset-version | Primary THA Procedure version: 20230831 |
| default-valueset-version | Lower Body Fractures Excluding Ankle and Foot version: 20230722 |
| default-valueset-version | Partial Arthroplasty of Hip version: 20230722 |
| default-valueset-version | Removal, Revision and Supplement Procedures of the Lower Body and Spine version: 20230722 |
| default-valueset-version | Malignant Neoplasms of Lower and Unspecified Limbs version: 20230722 |
| default-valueset-version | Mechanical Complications Excluding Upper Body version: 20230722 |
| default-valueset-version | Encounter to Document Medications version: 20210220 |
| system-version | US Core Condition Category Extension Codes version: 7.0.0 |
| default-valueset-version | Follow Up for Above Normal BMI version: 20190314 |
| default-valueset-version | Referrals Where Weight Assessment May Occur version: 20170504 |
| default-valueset-version | Medications for Above Normal BMI version: 20210220 |
| default-valueset-version | Overweight or Obese version: 20180309 |
| default-valueset-version | Follow Up for Below Normal BMI version: 20200307 |
| default-valueset-version | Medications for Below Normal BMI version: 20210220 |
| default-valueset-version | Underweight version: 20220302 |
| default-valueset-version | Encounter to Evaluate BMI version: 20210220 |
| default-valueset-version | Pregnancy Obstetric or Maternal Diagnoses version: 20210220 |
| default-valueset-version | Atrial Ablation version: 20210220 |
| default-valueset-version | History of Atrial Ablation version: 20221115 |
| default-valueset-version | Anticoagulant Therapy version: 20240206 |
| default-valueset-version | Thrombolytic tPA Therapy version: 20210220 |
| default-valueset-version | Intravenous or Intraarterial Thrombolytic tPA Therapy version: 20210220 |
| default-valueset-version | Intravenous or Intraarterial Thrombolytic tPA Therapy Prior to Arrival version: 20210220 |
| default-valueset-version | Fluoride Varnish Application for Children version: 20210928 |
| default-valueset-version | Clinical Oral Evaluation version: 20170504 |
| default-valueset-version | Dental Caries version: 20210220 |
| default-valueset-version | Hypoglycemics Severe Hypoglycemia version: 20240117 |
| default-valueset-version | Glucose Lab Test Mass Per Volume version: 20230203 |
| default-valueset-version | Opioid Antagonist version: 20240124 |
| default-valueset-version | Opioids, All version: 20240124 |
| default-valueset-version | Operating Room Suite version: 20220512 |
| default-valueset-version | Routes of Administration for Opioid Antagonists version: 20230204 |
| default-valueset-version | Pressure Injury Deep Tissue Diagnoses version: 20220415 |
| default-valueset-version | Pressure Injury Stage 2, 3, 4 or Unstageable version: 20220415 |
| default-valueset-version | Pressure Injury Stage 2, 3, 4, or Unstageable Diagnoses version: 20220416 |
| default-valueset-version | Creatinine Mass Per Volume version: 20220415 |
| default-valueset-version | Obstetrics and VTE Obstetrics version: 20220415 |
| default-valueset-version | Hospital Based Dialysis Services version: 20230205 |
| default-valueset-version | High Risk Diagnosis for AKI version: 20240112 |
| default-valueset-version | High Risk Procedures for AKI version: 20230205 |
| default-valueset-version | Hypoglycemics Treatment Medications version: 20240118 |
| default-valueset-version | Estimated Glomerular Filtration Rate version: 20190531 |
| default-valueset-version | Urine Albumin Creatinine Ratio version: 20190531 |
| default-valueset-version | Urine Albumin version: 20231019 |
| default-valueset-version | Urine Creatinine version: 20231019 |
| default-canonical-version | CQFM Continuous Variable Measure version: 4.0.0 |
| default-canonical-version | CMS986FHIRMalnutritionScore version: 1.0.000 |
| default-valueset-version | STEMI version: 20190216 |
| default-valueset-version | Fibrinolytic Therapy version: 20230218 |
| default-valueset-version | Percutaneous Coronary Intervention version: 20180523 |
| default-valueset-version | Thrombolytic medications version: 20211007 |
| default-valueset-version | Thrombolytics Adverse Event version: 20230218 |
| default-valueset-version | Active Bleeding Excluding Menses or Bleeding Diathesis version: 20190216 |
| default-valueset-version | Malignant Intracranial Neoplasm Group version: 20211005 |
| default-valueset-version | Cerebral Vascular Lesion version: 20190216 |
| default-valueset-version | Dementia and Related Intracranial Pathologies version: 20190216 |
| default-valueset-version | Pregnancy ICD10 SNOMEDCT version: 20190216 |
| default-valueset-version | Allergy to thrombolytics version: 20211007 |
| default-valueset-version | Oral Anticoagulant Medications version: 20230218 |
| default-valueset-version | Aortic Dissection or Ruptured Aortic Aneurysm version: 20190216 |
| default-valueset-version | Neurologic impairment version: 20240217 |
| default-valueset-version | Cardiopulmonary Arrest version: 20190216 |
| default-valueset-version | Major Surgical Procedure version: 20190216 |
| default-valueset-version | Endotracheal Intubation version: 20170504 |
| default-valueset-version | Insertion or Replacement of Mechanical Circulatory Assist Device version: 20220209 |
| default-valueset-version | Closed Head and Facial Trauma version: 20190216 |
| default-valueset-version | Acute Peptic Ulcer version: 20190216 |
| default-valueset-version | Intracranial or Intraspinal surgery version: 20220218 |
| default-canonical-version | CQFM Cohort Measure version: 4.0.0 |
| default-valueset-version | Medicare FFS payer version: 20230214 |
| default-valueset-version | Medicare Advantage payer version: 20230214 |
| default-valueset-version | Oxygen Saturation by Pulse Oximetry version: 20230214 |
| default-valueset-version | Potassium lab test version: 20230214 |
| default-valueset-version | Glucose lab test version: 20230214 |
| default-canonical-version | US Core Pulse Oximetry Profile version: 7.0.0 |
| default-canonical-version | Device version: 4.0.1 |
| default-canonical-version | US Core Vital Signs Profile version: 7.0.0 |
| default-canonical-version | US Core Specimen Profile version: 7.0.0 |
| default-canonical-version | NHSNGlycemicControlHypoglycemiaInitialPopulation version: 1.1.000 |